12th Conference on Retrovirus and Opportunistic Infections, 22-25 February, Boston, 2005

Reports from the conference

As is customary for this scientific meeting, Retrovirus this year provided an opportunity for important research.

Abstracts from this meeting are posted to the conference website, and many pdf for poster presentations are also already online:

There was a wealth of exciting data on new compounds with an indication to work against currently resistant HIV, and important overviews that this year are available as online webcasts, with slides.

Particularly recommended presentations include:

February 23, 2005

Plenary: Nevirapine and PMTCT

  • Controversies in the use of nevirapine for the prevention of mother-to-child transmission – James McIntyre

Symposium: Chemokine Receptor Blockade: Bench to Bedside

  • Preclinical development of chemokine receptor inhibitors – Donald E Mosier
  • Clinical activity and efficacy trials of chemokine receptor inhibitors – Daniel Kuritzkes

Symposium: Heart and HAART

  • Cardiovascular risk prediction in the general population – Jorge Plutzky
  • Cardiovascular outcomes in HIV infection – Jens D Lundgren
  • Managing cardiovascular risk and lipid disorders – Esteban Martinez

February 24, 2005

Plenary: Lipodystrophy

  • Fitting the pieces of the puzzle – Peter Reiss

Symposium: Critical Paediatric Issues in Developing Countries

  • Safer breastfeeding for babies born to HIV-positive mothers: part of the answer to a dilemma – Jean Humphrey
  • Is early diagnosis of HIV infection feasible in resource-limited settings? – Christine Rouzioux
  • Paediatric antiretroviral therapy: challenges and triumphs – Diana Gibb

Special Symposium: Transmitted HIV-1 Drug Resistance and Rapid Disease Progression

  • Introductory remarks and summary of case report of recent infection by a multi-drug resistant, dual-tropic HIV-1 in association with rapid progression to AIDS – David Ho
  • Variations in the natural history of HIV infection in the NIAID Multicenter AIDS Cohort Study (MACS) and the Women’s Interagency HIV Study (WIHS) – Stephen Gange
  • Variations in the natural history of HIV seroconverters in US military cohorts – Matthew Dolan
  • Transmission of drug resistant HIV: frequency, transmissibility, and fitness – Andrew Leigh Brown
  • Public health aspects of the NYC case – Harold Jaffe

With over 900 studies and presentations we are only able to include a few reports in this issue of HTB. Further reports will follow in the next issue.

The conference is the focus of many online web reports which are also recommended.

Amongst the most useful include:

National AIDS Treatment Advocacy Project – NATAP.

The Body

HIV and


Clinical Care Options

Reports in this issue include:

Links to other websites are current at date of posting but not maintained.